Published in Stroke on March 17, 2005
Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect. N Engl J Med (2009) 4.45
Overview and findings from the religious orders study. Curr Alzheimer Res (2012) 3.46
The TMEM106B locus and TDP-43 pathology in older persons without FTLD. Neurology (2015) 2.81
Cognitive impact of subcortical vascular and Alzheimer's disease pathology. Ann Neurol (2006) 2.62
Microvascular brain pathology and late-life motor impairment. Neurology (2013) 1.64
Neuropathologic intermediate phenotypes enhance association to Alzheimer susceptibility alleles. Neurology (2009) 1.63
The APOE epsilon4 allele is associated with incident mild cognitive impairment among community-dwelling older persons. Neuroepidemiology (2009) 1.35
Where vascular meets neurodegenerative disease. Stroke (2010) 1.35
Cerebrovascular disease pathology and parkinsonian signs in old age. Stroke (2011) 1.30
Apolipoprotein E e4 allele is associated with more rapid motor decline in older persons. Alzheimer Dis Assoc Disord (2009) 1.22
Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer disease. Ann Neurol (2015) 1.03
Low HDL Cholesterol is Associated with Lower Gray Matter Volume in Cognitively Healthy Adults. Front Aging Neurosci (2010) 1.03
The association of APOE genotype and cognitive decline in interaction with risk factors in a 65-69 year old community sample. BMC Geriatr (2008) 1.02
A 2-process model for neuropathology of Alzheimer's disease. Neurobiol Aging (2013) 1.02
Disentangling the effects of age and APOE on neuropathology and late life cognitive decline. Neurobiol Aging (2013) 1.00
Estimation of causal mediation effects for a dichotomous outcome in multiple-mediator models using the mediation formula. Stat Med (2013) 0.90
APOE ε4, Alzheimer's disease pathology, cerebrovascular disease, and cognitive change over the years prior to death. Psychol Aging (2013) 0.87
The effect of APOE-epsilon4 on dementia is mediated by Alzheimer neuropathology. Alzheimer Dis Assoc Disord (2009) 0.86
APOE and cerebral amyloid angiopathy in community-dwelling older persons. Neurobiol Aging (2015) 0.84
Residual decline in cognition after adjustment for common neuropathologic conditions. Neuropsychology (2014) 0.81
Relation of genomic variants for Alzheimer disease dementia to common neuropathologies. Neurology (2016) 0.80
Association between apolipoprotein E polymorphism and subclinic atherosclerosis in patients with type 1 diabetes mellitus. J Clin Res Pediatr Endocrinol (2012) 0.80
Purpose in life and cerebral infarcts in community-dwelling older people. Stroke (2015) 0.79
Association of APOE with tau-tangle pathology with and without β-amyloid. Neurobiol Aging (2015) 0.77
Role of APOE ε4 Allele and Incident Stroke on Cognitive Decline and Mortality. Alzheimer Dis Assoc Disord (2016) 0.75
TDP-43 pathology and memory impairment in elders without pathologic diagnoses of AD or FTLD. Neurology (2017) 0.75
Two shorter forms of the CES-D (Center for Epidemiological Studies Depression) depression symptoms index. J Aging Health (1993) 11.92
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology (2006) 8.97
An improved and simplified method of detecting the acetylator phenotype. J Med Genet (1969) 6.40
Natural history of mild cognitive impairment in older persons. Neurology (2002) 6.09
Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology (2005) 5.76
A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population. J Med Genet (1980) 5.68
Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050. Alzheimer Dis Assoc Disord (2001) 5.09
MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease. Neurobiol Aging (2001) 4.54
Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease. Int J Neurosci (1991) 4.53
Steady-state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy. Br Med J (1969) 4.21
Latent Semantic Indexing of medical diagnoses using UMLS semantic structures. Proc Annu Symp Comput Appl Med Care (1991) 4.09
Total daily physical activity and the risk of AD and cognitive decline in older adults. Neurology (2012) 4.09
Maintaining mobility in late life. I. Demographic characteristics and chronic conditions. Am J Epidemiol (1993) 3.74
Mild cognitive impairment: risk of Alzheimer disease and rate of cognitive decline. Neurology (2006) 3.71
Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens (2003) 3.67
Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology (2004) 3.61
Nomenclature for N-acetyltransferases. Pharmacogenetics (1995) 3.59
Proneness to psychological distress is associated with risk of Alzheimer's disease. Neurology (2003) 3.59
Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med (1996) 3.48
Established populations for epidemiologic studies of the elderly: study design and methodology. Aging (Milano) (1993) 3.47
Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology (2002) 3.40
Fibrodysplasia ossificans progressiva. The clinical features and natural history of 34 patients. J Bone Joint Surg Br (1982) 3.39
Education modifies the relation of AD pathology to level of cognitive function in older persons. Neurology (2003) 3.35
Relation of cognitive activity to risk of developing Alzheimer disease. Neurology (2007) 3.34
Age-specific incidence of Alzheimer's disease in a community population. JAMA (1995) 3.09
Delirium. The occurrence and persistence of symptoms among elderly hospitalized patients. Arch Intern Med (1992) 2.92
Blood glucose and risk of cardiovascular disease in the Asia Pacific region. Diabetes Care (2004) 2.77
Cognitive activity and incident AD in a population-based sample of older persons. Neurology (2002) 2.77
Depressive symptoms and cognitive decline in a community population of older persons. J Neurol Neurosurg Psychiatry (2004) 2.67
A prospective study of incident comprehensive medical home care use among the elderly. Am J Public Health (1988) 2.67
Social resources and cognitive decline in a population of older African Americans and whites. Neurology (2004) 2.66
Relation of cerebral infarctions to dementia and cognitive function in older persons. Neurology (2003) 2.60
Change in body mass index and risk of incident Alzheimer disease. Neurology (2005) 2.48
Diabetes is related to cerebral infarction but not to AD pathology in older persons. Neurology (2006) 2.48
MRI predictors of risk of incident Alzheimer disease: a longitudinal study. Neurology (2005) 2.48
Cognitive decline in incident Alzheimer disease in a community population. Neurology (2010) 2.41
Neurodegenerative basis of age-related cognitive decline. Neurology (2010) 2.41
Chronic distress and incidence of mild cognitive impairment. Neurology (2007) 2.33
Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease. Neurology (2003) 2.32
Cognitive activity in older persons from a geographically defined population. J Gerontol B Psychol Sci Soc Sci (1999) 2.31
Parkinsonian signs in subjects with mild cognitive impairment. Neurology (2005) 2.30
MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD. Neurobiol Aging (2004) 2.29
Kidney function is associated with the rate of cognitive decline in the elderly. Neurology (2009) 2.27
Correlates of cognitive function in an elderly community population. Am J Epidemiol (1988) 2.26
Ocular fireworks injuries and blindness. An analysis of 154 cases and a three-state survey comparing the effectiveness of model law regulation. Ophthalmology (1982) 2.25
Chiral bis(oxazoline) copper(II) complexes: versatile catalysts for enantioselective cycloaddition, Aldol, Michael, and carbonyl ene reactions. Acc Chem Res (2000) 2.22
Age of Neoproterozoic bilatarian body and trace fossils, White Sea, Russia: implications for metazoan evolution. Science (2000) 2.21
Terminal decline in cognitive function. Neurology (2003) 2.18
Oxcarbazepine adjunctive therapy in infants and young children with partial seizures. Neurology (2005) 2.13
A randomized clinical trial of anticaries therapies targeted according to risk assessment (caries management by risk assessment). Caries Res (2012) 2.08
Cognitive activity and cognitive decline in a biracial community population. Neurology (2003) 2.06
Initial diagnoses given to persons with the fragile X associated tremor/ataxia syndrome (FXTAS). Neurology (2005) 2.04
Statins, incident Alzheimer disease, change in cognitive function, and neuropathology. Neurology (2008) 1.97
Epidemiology of disability in the oldest old: methodologic issues and preliminary findings. Milbank Mem Fund Q Health Soc (1985) 1.94
Cadaveric study of movement of an unstable atlanto-axial (C1/C2) cervical segment during laryngoscopy and intubation using the Airtraq(®) , Macintosh and McCoy laryngoscopes. Anaesthesia (2014) 1.93
Frequencies of the defective CYP2C19 alleles responsible for the mephenytoin poor metabolizer phenotype in various Oriental, Caucasian, Saudi Arabian and American black populations. Pharmacogenetics (1997) 1.92
The genetic control of sparteine and debrisoquine metabolism in man with new methods of analysing bimodal distributions. J Med Genet (1983) 1.92